coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Gravesend Alliance PCN, Gravesham · Health Inequalities Profile

    PCN U08711 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,708

    Registered population

    60.4% aged 18–64

    14.6%

    Aged 65+

    ICB 19.9% · England 17.9%

    27.1%

    Ethnic minority (non-White)

    12.2% Asian · England 9.6%

    29.4%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~12,842

    Core20 residents (est.)

    Resident basis; registered basis ~14,755 · see page 3

    6,481

    Hypertension register

    +6.96% in 3 yrs · England +5.60%

    352

    SMI register

    38.1% of Gravesham's

    842

    COPD register

    Reviews -0.90% in 3 yrs

    Forecast to 2030

    7,670

    Hypertension patients, 2030

    +1,189 on today

    64.5%

    QRISK ≥20% on statins, 2030

    +2.55pp over 3 yrs

    3.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    54.9%
    Asthma annual reviews trail local and national benchmarks.

    Annual reviews reached 54.9% (Gravesham 58.5%, England 65.7%), a 1,044 scale gap across 2,315 patients that may reflect recall bottlenecks to test locally.

    -17.2%
    Heart failure and hypertension monitoring fell since 2023.

    From 2023 to 2025, heart failure reviews changed -17.2% (England +8.7%) to 63.6% and hypertension BP checks changed -2.9% (England +3.6%) to 82.0%.

    +9.2%
    Diabetes statin prescribing and psychosis checks outpaced England.

    Over 2023 to 2025, statin prescribing in diabetes without CVD grew +9.2% (England +2.1%) to 73.7%, and psychosis alcohol recording rose +15.2 pp.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients include 25.1% aged 0-17 and 27.1% non-White residents, exceeding national shares

    Gravesend Alliance PCN serves 48,708 registered patients, with 25.1% (12,203) aged 0-17, above Gravesham (22.1%), NHS Kent and Medway ICB (20.7%) and England (19.6%). Conversely, 14.6% (7,110) are aged 65+, below Gravesham (16.2%), the ICB (19.9%) and England (17.9%). Census usual residents in PCN-associated areas are 27.1% non-White, including 12.2% Asian / Asian British and 8.7% Black / African / Caribbean / Black British, compared to Gravesham (11.2%, 6.5%), the ICB (4.7%, 3.1%) and England (9.6%, 4.2%).

    Age profile

    0–1725.1%
    18–6460.4%
    65+14.6%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White72.9%
    Asian12.2%
    Black8.7%
    Other3.2%
    Mixed3.1%

    Older people · falls rows are Gravesham local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Gravesham LA)2,0112,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)71.1%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)50.1%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Gravesham LA)1,0559819552024/25
    Falls deaths, all ages, per 100,000 (Gravesham LA)13.114.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 29.4% and varies by 17.9 percentage points across practices

    The PCN Core20 cohort comprises 29.4% of registered patients, above Gravesham (25.0%), NHS Kent and Medway ICB (17.1%) and England (21.0%). Deprivation is uneven across member practices, spanning a 17.9 pp range from The Shrubbery Surgery (19.9%) to Oakfield Health Centre, Practice 2 (37.8%). Springhead Health holds the largest volume with 7,565 estimated Core20 patients (35.0%). A 0.92 pp reconciliation gap separates the PCN rate from the 30.3% weighted practice share. Outreach planning could balance practice concentration against casework volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Oakfield , 237.8% · 3,798 patients
    Springhead Health35.0% · 7,565 patients
    Shrubbery19.9% · 3,392 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    352

    SMI register

    0.71% recorded prevalence

    333

    Learning disability register

    0.67% recorded prevalence

    15

    Care homes, 591 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Gravesham, Census 2021

    The PCN registers 352 severe mental illness patients (0.7% vs England 1.0%) and 333 learning disability patients (0.7% vs England 0.6%), alongside 15 catchment care homes (591 beds). Borough-level data records 8 rough sleepers in Gravesham in 2025. Crude register prevalence and catchment bed capacity do not establish resident registrations or unmet need, which primary care record audits would need to evaluate.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 75.2% (England 83.4%), with Springhead Health at 71.0%, while BMI checks reached 73.9% (England 82.1%). Both physical health check elements trail national benchmarks across member practices.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,481

    Hypertension register

    +6.96%

    Register growth, 3 yrs

    Gravesham +4.52% · England +5.60%

    +0.39pp

    BP control, under 80

    ≤140/90 · +1.31pp aged 80+

    +1,189

    More patients by 2030

    Forecast 7,670 (15.00%)

    Hypertension case-finding and control

    Hypertension prevalence is 13.1% (6,481 patients), below Gravesham (14.1%), NHS Kent and Medway ICB (16.2%), and England (15.2%), though unadjusted rates do not confirm under-detection (+396 to +937 benchmark range). For registered patients, recent blood pressure recording fell 2.9% over 2023 to 2025 (England +3.6%) to 82.0% (England 90.0%). Treatment to target stands at 62.7% (England 70.3%), and blood pressure <= 140/90 mmHg in patients under 80 is 59.5% (England 67.8%). Routine blood pressure monitoring and control trail national benchmarks, so clinical teams should prioritise recalling hypertensive patients whose readings are missing or above threshold.

    Lipids and statins

    Among patients with QRISK >= 20%, 59.1% receive lipid-lowering therapy, below England (63.6%) and NHS Kent and Medway ICB (61.4%) though above Gravesham (58.9%). Statin coverage in chronic kidney disease is 66.1% (England 70.3%). Lower uptake in QRISK >= 20% and CKD cohorts indicates scope to review treatment coverage.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202668,672£2.10£1.90£1.86£144,211
    Cardiovascular (all), 202594,766£3.73£3.57£3.33£353,477

    In 2026, 68,672 lipid-regulating drug items were prescribed at £2.10 per item, above Gravesham (£1.61), NHS Kent and Medway ICB (£1.90), and England (£1.86), representing £16,481 more than at England's unit cost. Higher unit spend suggests scope to audit formulary choices alongside clinical targets.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.16%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.60%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual reviews reached 54.9%, trailing Gravesham (58.5%), NHS Kent and Medway ICB (60.4%) and England (65.7%), indicating an unreviewed scale gap of 1,044 patients across the 2,315 register. Reviews span from 45.2% at Oakfield Health Centre, Practice 2 to 63.8% at Springhead Health. Meanwhile, across 842 COPD patients, review completion was 69.8% (England 76.4%), with a three-year change of -0.9% over 2023 to 2025 (England +2.8%).

    Cancer register and children's immunisation

    Cancer prevalence is 2.9% (England 3.8%) across 1,452 registered patients. In Q1 2025/26, 6-in-1 coverage at 12 months was 87.9% (England 91.0%, target 95%). At age 5, Gravesend Alliance PCN achieved 94.1% MMR dose 1 coverage and 85.0% MMR dose 2 coverage, reflecting a 9.1 pp same-cohort difference. At The Shrubbery Surgery, the same-cohort difference between first and second dose was 13.6 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months87.9%

    England 91.0%

    6-in-1 complete primary course at 24 months92.2%

    England 92.2%

    MMR dose 1 at 24 months88.2%

    England 88.3%

    MMR dose 2 at age 585.0%

    England 82.8%

    4-in-1 pre-school booster at age 584.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Across NHS Kent and Medway ICB in 2022, 55.6% of staged cancers were diagnosed at stage 1 or 2 (England 55.3%), 19.4 pp below the 75.0% national ambition, with 1,627 extra early-stage cases required. Staging was known for 63.6% of cases (England 67.0%). Within primary care screening, PCN cervical coverage (25-49 yrs) was 66.5% (ICB 69.9%), varying from 60.8% at Springhead Health to 70.2% at The Shrubbery Surgery and 75.1% at Oakfield Health Centre, Practice 2, alongside breast screening coverage of 63.4% (England 69.9%). Targeted uptake initiatives at practices below benchmarks could reduce missed early detection opportunities.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Dartford and Gravesham NHS Trust achieved 63.6% on the 62-day cancer referral to treatment standard (standard 85.0%), trailing Medway NHS Foundation Trust (81.6%), NHS Kent and Medway Integrated Care Board (75.9%), and England (71.2%). On the 28-day faster diagnosis standard, Dartford and Gravesham NHS Trust reached 78.1% (Medway NHS Foundation Trust 77.8%, ICB 76.8%, England 79.3%), exceeding the 75.0% standard. Diagnostic 6-week waits stood at 8.4% at Dartford and Gravesham NHS Trust, compared with Medway NHS Foundation Trust (14.2%), Kent Community Health NHS Foundation Trust (27.5%), and England (23.1%).

    Pathways within standard (%)Dartford and GraveshamMedwayKent and Medway ICBEngland
    28-day faster diagnosis (75%)78.1477.7776.7879.32
    31-day treatment (96%)97.4899.6295.8492.50
    62-day referral to treatment (85%)63.5981.6475.9371.16
    Diagnostic waits over 6 weeks (%)Dartford and GraveshamKent HealthMedwayEngland
    MRI0.36—0.6821.40
    CT2.08—0.009.92
    Echocardiography3.90—36.6228.48
    Colonoscopy0.40—1.8830.83
    Gastroscopy0.00—3.3229.02
    All 15 DM01 tests8.3727.4914.2023.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). For Jun 2026 (provisional), experimental community data records 210,170 care contacts across Kent (60,605 patients with a contact) and 254,055 contacts across NHS Kent and Medway Integrated Care Board. Community care activities reached 265,905 in Kent and 297,595 for the ICB. In Kent, contacts with adults aged 65+ accounted for 65.8% of contacts. These figures reflect local authority and system activity rather than PCN-specific patient flows.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access varies by 49.5 pp across practices, which could reflect uneven demand

    In 2025/26, overall QOF achievement ranged from 85.8% at Oakfield Health Centre, Practice 2 to 89.5% at The Shrubbery Surgery (England 92.5%). Clinical achievement reached 98.8% at The Shrubbery Surgery. Vaccination and immunisation lagged England (55.2%) at captured practices, from 15.6% at The Shrubbery Surgery to 24.9% at Oakfield Health Centre, Practice 2 (a 9.3 pp spread).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Shrubbery7319.968.1%60.5%78.6%
    Springhead Health10235.018.6%63.5%68.2%
    Oakfield , 29437.852.1%73.2%66.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNGraveshamAssetPCNGravesham
    Care homes (catchment)15 (591 beds)n/aSchools (catchment)81n/a
    Children's centres65Places of worship3346
    Libraries68Food banks (VCS)11
    Day centres (VCS)913Children and young people (VCS)n/a1
    Carers support groups (VCS)n/a2Primary schools (LA maintained)1216
    Primary academies1416Special schools34

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual reviews reached 54.9% (Gravesham 58.5%, ICB 60.4%, England 65.7%), leaving a 1,044-patient scale gap across the 2,315 register (45.2% at Oakfield Health Centre, Practice 2). For discussion: the PCN could test a standardised asthma recall template with after-school and flexible clinic slots, reviewing inhaler prescribing alongside annual reviews. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension BP monitoring and recall

    Hypertension prevalence is 13.1% (6,481 patients; +396 to +937 benchmark range vs Gravesham 14.1% and England 15.2%); recent BP checks fell 2.9% (2023 to 2025) to 82.0% (England 90.0%) and control is 59.5% (England 67.8%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Long-term condition and SMI review audit

    Over 2023 to 2025, heart failure reviews (396 register) fell 17.2% to 63.6% (England 78.5%) and COPD reviews (842 register) fell 0.9% to 69.8% (England 76.4%); SMI BP checks (352 register) reached 75.2% (England 83.4%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric and diverse community outreach (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Dual-track Core20 resource allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster catch-up outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Hypertension BP monitoring and recall (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Long-term condition and SMI review audit (p12)Heart failure register · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs) · COPD registerMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15